scholarly article | Q13442814 |
review article | Q7318358 |
retracted paper | Q45182324 |
P50 | author | Alan P Knutsen | Q117269565 |
P2860 | cites work | Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae | Q24290929 |
The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor | Q24311786 | ||
IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary sspergillosis | Q25255557 | ||
Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis | Q28191440 | ||
The IL-4 receptor: signaling mechanisms and biologic functions | Q28198739 | ||
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference | Q28207287 | ||
Allergic bronchopulmonary aspergillosis | Q28213702 | ||
Allergic bronchopulmonary aspergillosis: staging as an aid to management | Q28277864 | ||
T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis | Q30448838 | ||
Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis | Q32030301 | ||
Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy | Q32065992 | ||
Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations | Q33179741 | ||
Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon | Q33614894 | ||
Molecular mechanisms of IgE regulation | Q33835041 | ||
Putative virulence factors of Aspergillus fumigatus | Q33863956 | ||
No association between atopy/asthma and the ILe50Val polymorphism of IL-4 receptor | Q77950317 | ||
Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis | Q81714704 | ||
Genetic and respiratory tract risk factors for aspergillosis: ABPA and asthma with fungal sensitization | Q92929050 | ||
Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon | Q123345942 | ||
Broncho-pulmonary aspergillosis; a review and a report of eight new cases | Q33968429 | ||
Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma | Q34687577 | ||
Lymphocytes in allergic bronchopulmonary aspergillosis | Q35109519 | ||
IL-13 receptors and signaling pathways: An evolving web | Q35110741 | ||
IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses | Q35601173 | ||
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis | Q35882858 | ||
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. | Q36261169 | ||
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling | Q36361605 | ||
Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes | Q37008593 | ||
Regulation of IgE synthesis by CD23/CD21 interaction | Q40402571 | ||
TLRs govern neutrophil activity in aspergillosis | Q40483206 | ||
Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma | Q40563836 | ||
Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production | Q40873595 | ||
A comparison of the prevalence of sensitization to antigens among asthmatics in Cleveland and London | Q40900426 | ||
The R576 IL-4 receptor alpha allele correlates with asthma severity. | Q40919437 | ||
Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. | Q40974167 | ||
Epithelial shedding--restitution as a causative process in airway inflammation | Q41140361 | ||
Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L. | Q41166361 | ||
Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis | Q41452252 | ||
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo | Q41761641 | ||
Interleukin 13 is a B cell stimulating factor | Q42075980 | ||
Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens | Q42155789 | ||
Putative association of a TLR9 promoter polymorphism with atopic eczema. | Q43693434 | ||
In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages. | Q43904136 | ||
Participation of cell-mediated immunity in allergic bronchopulmonary aspergillosis | Q45247496 | ||
Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial | Q47620055 | ||
Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma | Q47991914 | ||
Linkage and allelic association of atopy and markers flanking the IL4-receptor gene. | Q50900668 | ||
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. | Q51905170 | ||
Polymorphisms in Toll‐Like Receptor Genes and Susceptibility to Pulmonary Aspergillosis | Q56837281 | ||
Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case–control disease association studies☆☆This work was supported | Q57253814 | ||
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 | Q59089322 | ||
Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis | Q61508452 | ||
In vitro T cell responses in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis. | Q64938848 | ||
IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals | Q67884214 | ||
IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1 | Q67895106 | ||
A pathologic study of allergic bronchopulmonary aspergillosis | Q68132484 | ||
T- and B-cell dysregulation of IgE synthesis in cystic fibrosis patients with allergic bronchopulmonary aspergillosis | Q68410928 | ||
Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis | Q70642847 | ||
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides | Q70648993 | ||
Allergic bronchopulmonary aspergillosis in cystic fibrosis | Q71261436 | ||
Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells | Q71396762 | ||
The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function | Q71739883 | ||
Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice | Q72001569 | ||
Hypersensitivity disease of the lung | Q72030560 | ||
Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases | Q72376945 | ||
Allergic bronchopulmonary aspergillosis--a North American Rarity. Clinical and immunologic characteristics | Q72466147 | ||
Common polymorphisms in the coding part of the IL4-receptor gene | Q73156328 | ||
Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis | Q73367052 | ||
Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis | Q73385886 | ||
SP-A enhances uptake of bacillus Calmette-Guérin by macrophages through a specific SP-A receptor | Q73399676 | ||
Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines | Q73476118 | ||
The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis | Q73900195 | ||
V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function | Q74500179 | ||
The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction | Q77419252 | ||
Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia | Q77509497 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | aspergillosis | Q259626 |
allergic bronchopulmonary aspergillosis | Q1430844 | ||
P304 | page(s) | 785983 | |
P577 | publication date | 2011-09-28 | |
P1433 | published in | Journal of Allergy | Q24039111 |
P1476 | title | Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis | |
P478 | volume | 2011 |
Q38569609 | Allergic Inflammation in Aspergillus fumigatus-Induced Fungal Asthma. |
Q98215811 | Analysis of serum polyunsaturated fatty acid metabolites in allergic bronchopulmonary aspergillosis |
Q41964909 | Antifungal Treatments Delineate a Correlation between Cathepsins and Cytokines in Murine Model of Invasive Aspergillosis |
Q36302587 | B lymphocytes regulate airway granulocytic inflammation and cytokine production in a murine model of fungal allergic asthma. |
Q102068712 | Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis |
Q50915141 | Cytokine and transcription factor expression by Aspergillus fumigatus-stimulated peripheral blood mononuclear cells in dogs with sino-nasal aspergillosis. |
Q88015795 | Evaluation of murine lung epithelial cells (TC-1 JHU-1) line to develop Th2-promoting cytokines IL-25/IL-33/TSLP and genes Tlr2/Tlr4 in response to Aspergillus fumigatus |
Q38287190 | Immune responses to airborne fungi and non-invasive airway diseases |
Q34512982 | Innate and Adaptive Immunity in Cystic Fibrosis |
Q28265740 | Management of allergic bronchopulmonary aspergillosis: a review and update |
Q50946631 | Novel immunologic classification of aspergillosis in adult cystic fibrosis. |
Q55396588 | Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. |
Q46823221 | Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis |
Q53146228 | Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. |
Q43245538 | Retracted: Immunopathology and Immunogenetics of Allergic Bronchopulmonary Aspergillosis |
Q38241048 | The biology of pulmonary aspergillus infections |
Q91409787 | The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis |
Q36515696 | Two novel species of Aspergillus section Nigri from indoor air. |
Q42243852 | μ-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model |
Search more.